Skip to main content
. 2018 Oct 23;2018(10):CD012414. doi: 10.1002/14651858.CD012414.pub2

Summary of findings 2. Scheduled PDE5I compared to on demand placebo or no treatment for post‐prostatectomy erectile dysfunction (long‐term).

Scheduled PDE5I compared to on demand placebo or no treatment for post‐prostatectomy erectile dysfunction (long‐term)
Patient or population: post‐prostatectomy erectile dysfunction (long‐term)
 Setting: outpatient clinic
 Intervention: scheduled PDE5I
 Comparison: on demand placebo or no treatment
Outcomes № of participants
 (studies)
 Follow up Certainty of the evidence
 (GRADE) Relative effect
 (95% CI) Anticipated absolute effects* (95% CI)
Risk with on demand placebo or no treatment Risk difference with scheduled PDE5I
Self‐reported potency ‐ not reported
Erectile function ‐ not reported
Serious adverse events ‐ not reported
Sexual quality of life
 assessed with: Expanded Prostate Cancer Index Composite (sexual domain)
 Scale from: 0 (worst) to 100 (best)
 follow up: mean 54 weeks 280
 (1 RCT) ⊕⊕⊕⊝
 MODERATE 1 The mean quality of life was 33.4 MD 3.2 higher
 (5.91 lower to 12.31 higher)
Treatment discontinuation
 follow up: mean 54 weeks 420
 (1 RCT) ⊕⊕⊕⊝
 MODERATE 1 RR 1.12
 (0.85 to 1.48) Study population
310 per 1,000 37 more per 1,000
 (46 fewer to 149 more)
International Index of Erectile Function ‐ not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 
 CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;
GRADE Working Group grades of evidenceHigh certainty: We are very confident that the true effect lies close to that of the estimate of the effect
 Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
 Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
 Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 Downgraded by one level for imprecision: confidence interval crosses assumed threshold of clinically important difference.